Liothyronine (LT3) prescribing in england - are cost constraints inhibiting guideline implementation?

Adrian Heald(Manchester Academic Health Science Centre), Colin Dayan(University of Birmingham), Lakdasa Premawardhana(Ysbyty Ystrad Fawr), Mike Stedman, Onyebuchi Okosieme(Cwm Taf University Health Board), Peter Taylor(University Hospital of Wales), John Warner‐Levy, Nadia Chaudhury(University Hospitals Coventry and Warwickshire NHS Trust)
Endocrine Abstracts
May 6, 2024
10.1530/endoabs.99.ep361
Cited by 0

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
|The Lancet Psychiatry|2019|1.5k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
|JAMA|2019|395
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
|Nature Reviews Endocrinology|2019|315